Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups
about
sameAs
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular diseaseClopidogrel plus aspirin versus aspirin alone for preventing cardiovascular diseaseAntithrombotic treatment of NSTEMI/UAP. The interaction with PCIThe role of antiplatelet therapy in the management of acute coronary syndromesCLARITY about the use of clopidogrel in patients with acute coronary syndromes and myocardial infarctionClopidogrel in acute coronary heart diseaseBest evidence topic report. Clopidogrel plus aspirin or aspirin alone in unstable anginaLong term clinical outcome and bleeding complications among hospital survivors with acute coronary syndromesRole of clopidogrel in unstable angina and non-ST-segment elevation myocardial infarction: from literature and guidelines to practiceContemporary management of acute coronary syndromeClopidogrel in the treatment of ischaemic heart diseaseClopidogrel in addition to aspirin reduces one-year major adverse cardiac and cerebrovascular events in unselected patients with non-ST segment elevation myocardial infarctionProlonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populationsComplementary prognostic values of ST segment deviation and Thrombolysis In Myocardial Infarction (TIMI) risk score in non-ST elevation acute coronary syndromes: Insights from the Platelet Receptor Inhibition in Ischemic Syndrome Management in PatieNon ST-elevation acute coronary syndrome.Application of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population.Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial.Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome.A Novel Risk Stratification Model for Patients with Non-ST Elevation Myocardial Infarction in the Korea Acute Myocardial Infarction Registry (KAMIR): Limitation of the TIMI Risk Scoring System.Clopidogrel in non-ST segment elevation acute coronary syndromes: an overview of the submission by the British Cardiac Society and the Royal College of Physicians of London to the National Institute for Clinical Excellence, and beyond.National Quality Assessment of Early Clopidogrel Therapy in Chinese Patients With Acute Myocardial Infarction (AMI) in 2006 and 2011: Insights From the China Patient-Centered Evaluative Assessment of Cardiac Events (PEACE)-Retrospective AMI StudyClopidogrel use in coronary artery disease.A Review of Current Diagnosis, Investigation, and Management of Acute Coronary Syndromes in Elderly Patients.Non ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm.Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelinesClopidogrel resistance--the cardiologist's perspective.Outcomes According to Cardiac Catheterization Referral and Clopidogrel Use Among Medicare Patients With Non-ST-Segment Elevation Myocardial Infarction Discharged Without In-hospital RevascularizationAcute coronary syndrome (unstable angina and non-ST elevation MI).Role of antiischemic agents in the management of non-ST elevation acute coronary syndrome (NSTE-ACS).A comprehensive review of predictive and prognostic composite factors implicated in the heterogeneity of treatment response and outcome across disease areas.InforMatrix: ADP antagonists in acute coronary syndromes.Safety of endobronchial ultrasound-guided transbronchial needle aspiration for patients taking clopidogrel: a report of 12 consecutive cases.Antiplatelet drug use in patients with non-ST-segment elevation acute coronary syndromes.Female gender and cardiovascular disease.Antiplatelet Therapy and Spontaneous Retroperitoneal Hematoma: A Case Report and Literature Review.Endoscopy in Patients on Antiplatelet Agents and Anticoagulants.ProFESS trial: any lessons to learn for future anti-platelet trials?Clopidogrel: cardiologists' panacea or neurologists' headache?Adding clopidogrel to aspirin improves outcome in ST-elevation myocardial infarction patients receiving fibrinolytic therapy.Evolving role of clopidogrel in acute coronary syndromes.
P2860
Q24234632-70FB3E65-0B07-4A1A-AA21-7C4D1F8C9133Q24243939-5A0B0D77-AC46-4330-A9BE-13F1D47445B1Q28169027-EAFFA2D0-FA74-4E35-A378-E229B95AC179Q28176548-06CA5DB4-4E39-4F57-8A78-0DCCA686C76AQ28186321-AC260329-B8B1-41C8-9778-B0ED0339105BQ28193776-9CFE8B50-5276-48D7-B0E1-D95E1F9598B5Q28194654-602F7D15-72CE-4252-BD18-41D9BCF3BBEDQ28195530-164DA05E-FA36-493C-B9BA-173F5F9985B4Q28211998-520FFFC0-8171-464D-9890-1C7DB101CA24Q28212068-BD45B210-2FAA-43D2-BBB7-8DF0536CE7E2Q28218576-2601C467-B56E-40A2-8430-96BB746E622BQ28222524-BCED1FD2-E9AB-4AFF-81EF-7E1E5D92533DQ28600880-E80BF7D7-9944-47CE-823B-DDF19B191ED0Q33595946-4814DA1C-123D-4CB2-88F3-34547263EE59Q33846765-B19ACCE8-AD0C-46CF-8846-63A8D3CFBA87Q34478087-59B0D3A9-62F7-408B-8EF7-F1E2775A7F30Q35051753-453E775D-A95A-4F0E-B6EB-B3518BC61C0DQ35095856-ECD41FBA-4141-49EF-819D-59BEBD91C2DBQ35546171-A81D3894-ADBF-46E5-90B2-02997CDCDDBDQ35584682-326CA28D-6080-48AF-ABAC-E99E87E8FCE9Q36168738-9C73DF78-35CD-454C-AD27-8868FA00BB54Q36351993-324BF573-0AD0-4D0B-8DCF-E8D50C8DE8BBQ36363183-AE029FD2-08BB-41EA-BD02-F6AD55C4D49BQ36519924-31BBC58E-C6EC-4CC3-A5FB-EBB74BAF69C7Q36682317-48898418-B1F9-4CF0-837E-639DBB1F22C1Q36819608-9577BCD8-C68D-4CC7-A016-1C7034386937Q37090758-EFE305D5-58B8-4FCE-9BF5-F1E82C50E154Q37484189-5510395C-B711-4B0F-89B0-3CF2ABA227CCQ37788728-49E0C3B7-6DE3-483F-B2D7-04B5BDB8BE61Q37896168-06621475-6919-4ED2-9681-C0FDB678A514Q37973397-1C2D558B-E7BA-4E57-AC02-5902BAEF37A3Q37979654-C391EBD1-29F8-485A-9376-085C72B834BDQ38079917-469328D3-B72C-4277-967E-D6ED7B6B85E4Q38917090-599441B6-5E19-4E1C-8F5E-DEE620D83F60Q39101773-0B53B34E-A538-4D42-9C64-8B06E29F5985Q39328083-5F68CA64-1C95-4BD2-987F-5608861CE3F2Q39927164-3A4FA5D5-07D8-4147-ABEF-91D257E14995Q40393685-748E6966-0AB4-40FA-9005-FE60CB4B926DQ43266392-0A0A3FF4-172B-4C97-948C-7EB99885D67CQ46808753-7FEEE6E7-24AD-4868-850E-33DABC55E8B5
P2860
Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Benefit of clopidogrel in pati ...... evation in various risk groups
@ast
Benefit of clopidogrel in pati ...... evation in various risk groups
@en
Benefit of clopidogrel in pati ...... evation in various risk groups
@nl
type
label
Benefit of clopidogrel in pati ...... evation in various risk groups
@ast
Benefit of clopidogrel in pati ...... evation in various risk groups
@en
Benefit of clopidogrel in pati ...... evation in various risk groups
@nl
prefLabel
Benefit of clopidogrel in pati ...... evation in various risk groups
@ast
Benefit of clopidogrel in pati ...... evation in various risk groups
@en
Benefit of clopidogrel in pati ...... evation in various risk groups
@nl
P2093
P50
P3181
P1433
P1476
Benefit of clopidogrel in pati ...... evation in various risk groups
@en
P2093
Andrzej Budaj
David Hunt
Keith A A Fox
Matyas Keltai
Shamir R Mehta
P304
P3181
P356
10.1161/01.CIR.0000029926.71825.E2
P407
P577
2002-09-24T00:00:00Z